Johnson & Johnson

Transformational innovation takes many forms, but it always starts with one goal: improving patients' lives. We're honored that eight Johnson & Johnson innovations have been nominated for the 2026 Prix Galien USA and International Awards across three categories: Best Biotechnology Product, Best Pharmaceutical Product and Best Medical Technology. These nominations reflect the passion, ingenuity and dedication of our teams working every day to address some of the world's most pressing health challenges. Congratulations to all those whose work continues to expand what's possible for patients around the world. #PrixGalien #HealthcareInnovation

Leadership isn't defined by a title. It's a skillset to be developed at every stage of your career. Prioritizing learning takes practice, but it's what allows our people to grow, adapt and lead at every level. It's also why we set aside a full day each year to build new skills and sharpen how we show up for our teams and for each other. Curious what your career could look like here? Discover what's possible when learning is part of everyone's job description: https://lnkd.in/esczYtJK

AI is changing how we work—and how quickly we can deliver for patients. Through access, training and the encouragement to innovate responsibly, our teams are using AI to sharpen their expertise, reimagine how we work and accelerate what's possible in healthcare. See how continuous learning drives career growth at J&J: https://lnkd.in/enxmT8yh

For decades, monofocal lenses—designed for clear vision at a single distance—were the standard in cataract surgery. Advances in intraocular lens technology, digital tools and surgical planning are giving surgeons more ways to personalize treatment for each patient's unique needs. It's a shift we've helped drive for 25 years, advancing the technologies that support more personalized care. Read how innovation and clinical expertise are helping shape the future of eye health.

#NEWS: Today we’ve announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine following a distinguished career and over 21-year tenure at Johnson & Johnson. Jennifer will be succeeded by Tom Cavanaugh who currently serves as Company Group Chairman, North America, Innovative Medicine. Under Jennifer Taubert’s leadership, the Company’s Innovative Medicine business grew to more than $60 billion in annual revenue and strengthened its position as one of the most respected and successful pharmaceutical businesses in the world. "Jennifer has made an extraordinary impact on patients, our business, and generations of leaders across our Company," said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. "Her vision, leadership, unwavering commitment to healthcare innovation, and passion for talent development helped define an era of growth and position us for future success.” Tom Cavanaugh brings nearly three decades of biopharmaceutical experience and leadership across therapeutic areas, functions and geographies to the role.  “I am pleased to appoint Tom to this important role as we advance our pipeline and bring transformative medicines to patients around the world,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “I am confident his deep understanding of our business, proven track record of growth, and focus on developing people will ensure we are poised to continue to deliver for patients, healthcare systems, and our Company.” Jennifer and Tom will ensure a smooth transition that enables continued success. Tom will join the Johnson & Johnson Executive Committee, effective September 1, 2026.  Read more: https://lnkd.in/gRKC253Q

Supporting our employees through life’s most important moments is a key part of sustaining progress in healthcare innovation. Our expanded paid leave benefits are designed to provide the care and flexibility needed to navigate those moments—personally and professionally. In addition to vacation, sick days and holidays, our employees receive dedicated paid time off for specific life events, available from day one. Join a company that cares. Explore opportunities: https://lnkd.in/enUYbUf9

Join us tomorrow, July 15 at 8:30 AM ET for a live call and webcast as we share our Q2 2026 results. Register here: https://lnkd.in/djkgjJ3f #JNJ #earnings

Over 1 million people are diagnosed with bladder cancer every year. However, treatment options and outcomes remain challenging—highlighting the ongoing need for research in this area. Guided by his experience as a urologist, Christopher is now one of our scientists leading efforts to develop novel ways to deliver therapies and ensure these innovations are accessible to all patients. Read about how he and his team approach bladder cancer innovation.

From caring for patients in the oncology unit to leading global cancer trials, this nurse's career is a testament to how the profession plays a critical role in transforming lives. Melissa started at the bedside and now leads clinical trials in our Oncology Research & Development group to advance new therapies. She brings a nurse's instinct to every trial she designs, keeping the patient experience front and center. Read about how she's redefining what a nursing career can look like: https://lnkd.in/e3hAtCfG

As a company that prides itself on continuous learning, we foster curiosity and growth from day one. Through onboarding buddies, mentorship, coaching and personalized training, we support our employees at every stage—whether they’re building expertise or growing as people leaders. Explore how you can grow your career and shape the future of healthcare: https://lnkd.in/e_5xXUze